Methyldopa and propranolol or practolol in moderate hypertension

Area of Science:

• Cardiology
• Pharmacology

Background:

• Hypertension management often requires combination therapy.
• Beta-adrenoceptor antagonists and methyldopa are established antihypertensive agents.

Purpose of the Study:

• To evaluate the efficacy of low-dose methyldopa combined with non-selective (propranolol) and selective (practolol) beta-adrenoceptor antagonists in patients with moderate hypertension.
• To compare the combination therapies against monotherapy and placebo.

Main Methods:

• A double-blind, randomized crossover trial involving 24 patients with moderate hypertension.
• Patients received methyldopa, propranolol, practolol, methyldopa-propranolol combination, methyldopa-practolol combination, and placebo for four weeks each.

Main Results:

• The combination of methyldopa and propranolol significantly reduced lying and standing blood pressures.
• Methyldopa-propranolol showed greater reduction in diastolic blood pressure compared to methyldopa-practolol.
• Both combination therapies were more effective than monotherapy with either agent or placebo.

Conclusions:

• Combination therapy of methyldopa with propranolol is highly effective for moderate hypertension.
• The combination of methyldopa with a non-selective beta-blocker offers significant blood pressure control.